UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 224

Sortiert nach

Anemia in HIV Infection: Clinical Impact and Evidence-Based Management Strategies

Clinical infectious diseases, 2004-05, Vol.38 (10), p.1454-1463

2004

Volltextzugriff (PDF)

Serum Neopterin, an Immune Activation Marker, Independently Predicts Disease Progression in Advanced HIV-1 Infection

Clinical infectious diseases, 2005-03, Vol.40 (6), p.853-858

2005

Volltextzugriff (PDF)

Description of an efficacious behavioral peer-driven intervention to reduce racial/ethnic disparities in AIDS clinical trials

Health education research, 2013-08, Vol.28 (4), p.574-590

2013

Volltextzugriff (PDF)

Changes in Weight and Lean Body Mass during Highly Active Antiretroviral Therapy

Clinical infectious diseases, 2004-10, Vol.39 (8), p.1223-1230

2004

Volltextzugriff (PDF)

An Approach to the Validation of Markers for Use in AIDS Clinical Trials

Clinical infectious diseases, 1997-05, Vol.24 (5), p.764-774

1997

Volltextzugriff (PDF)

Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

The New England journal of medicine, 2008-05, Vol.358 (20), p.2095-2106

2008

Volltextzugriff (PDF)

Gender differences in attitudes toward AIDS clinical trials among urban HIV-infected individuals from racial and ethnic minority backgrounds

AIDS care, 2006-10, Vol.18 (7), p.786-794

2006

Volltextzugriff (PDF)

Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study

The Lancet infectious diseases, 2012, Vol.12 (1), p.27-35

2012

Volltextzugriff (PDF)

Safety and Immunogenicity of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B gag/pol/nef Vaccine in Healthy Adults

Clinical infectious diseases, 2008-06, Vol.46 (11), p.1769-1781

2008

Volltextzugriff (PDF)

Intranasal Transmission of Hepatitis C Virus: Virological and Clinical Evidence

Clinical infectious diseases, 2008-10, Vol.47 (7), p.931-934

2008

Volltextzugriff (PDF)

Predictors and Outcome of Multidrug-Resistant Tuberculosis

Clinical infectious diseases, 1995-11, Vol.21 (5), p.1245-1252

1995

Volltextzugriff (PDF)

Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points : A meta-analysis

AIDS research and human retroviruses, 2000-08, Vol.16 (12), p.1123-1133

2000

Volltextzugriff (PDF)

HIV Incidence Among Injection Drug Users in New York City, 1990 to 2002: Use of Serologic Test Algorithm to Assess Expansion of HIV Prevention Services

American journal of public health (1971), 2005-08, Vol.95 (8), p.1439-1444

2005

Volltextzugriff (PDF)

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

The New England journal of medicine, 1987-07, Vol.317 (4), p.192

1987

Volltextzugriff (PDF)

Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001

AIDS (London), 2005-10, Vol.19 Suppl 3 (Suppl 3), p.S20-S25

2005

Volltextzugriff (PDF)

Implications of Anemia in Human Immunodeficiency Virus, Cancer, and Hepatitis C Virus

Clinical infectious diseases, 2003-11, Vol.37 (Supplement-4), p.S293-S296

Mildvan, Donna

2003

Volltextzugriff (PDF)

Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients

HIV medicine, 2004-01, Vol.5 (1), p.55-65

2004

Volltextzugriff (PDF)

Comparative in-vitro activities of RP59500 (quinupristin/dalfopristin), CL 329,998, CL 331,002, trovafloxacin, clinafloxacin, teicoplanin and vancomycin against Gram-positive bacteria

Journal of antimicrobial chemotherapy, 1997-03, Vol.39 (3), p.405-409

1997

Volltextzugriff (PDF)

Comparison of Once-Daily versus Twice-Daily Combination Antiretroviral Therapy in Treatment-Naive Patients: Results of AIDS Clinical Trials Group (ACTG) A5073, a 48-Week Randomized Controlled Trial

Clinical infectious diseases, 2010-04, Vol.50 (7), p.1041-1052

2010

Volltextzugriff (PDF)

AIDS 1998. Clinical treatment: overview

AIDS (London), 1998, Vol.12 Suppl A, p.S147-S148

1998

Volltextzugriff (PDF)

Prevalence of human herpesvirus 8 DNA sequences in several patient populations

Journal of Clinical Microbiology, 1996-10, Vol.34 (10), p.2635-2638

1996

Volltextzugriff (PDF)

A Randomized, Partially Blinded Phase 2 Trial of Antiretroviral Therapy, HIV‐Specific Immunizations, and Interleukin‐2 Cycles to Promote Efficient Control of Viral Replication (ACTG A5024)

The Journal of infectious diseases, 2006-12, Vol.194 (12), p.1672-1676

2006

Volltextzugriff (PDF)

Outcomes by Sex Following Treatment Initiation With Atazanavir Plus Ritonavir or Efavirenz With Abacavir/Lamivudine or Tenofovir/Emtricitabine

Clinical infectious diseases, 2014-02, Vol.58 (4), p.555-563

2014

Volltextzugriff (PDF)

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials

Journal of antimicrobial chemotherapy, 2012-08, Vol.67 (8), p.2020-2028

2012

Volltextzugriff (PDF)

Once-Daily versus Twice-Daily Lopinavir/Ritonavir in Antiretroviral-Naive HIV-Positive Patients: A 48-Week Randomized Clinical Trial

The Journal of infectious diseases, 2004-01, Vol.189 (2), p.265-272

2004

Volltextzugriff (PDF)

1 – 25 von 224

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(200)
Mit Volltextzugriff
(165)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(159)
Life Sciences & Biomedicine
(150)
Humans
(136)
Biological And Medical Sciences
(105)
Male
(103)
Female
(85)
Adult
(81)
Medical Sciences
(78)
Aids/hiv
(73)
Infectious Diseases
(68)
Middle Aged
(51)
Immunology
(48)
Human Immunodeficiency Virus
(42)
Biochemistry & Molecular Biology
(41)
Hiv
(41)
Microbiology
(40)
Aids
(39)
Fundamental And Applied Biological Sciences. Psychology
(35)
Hiv Infections - Drug Therapy
(32)
General & Internal Medicine
(31)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Anemia in HIV Infection: Clinical Impact and Evidence-Based Management Strategies

Serum Neopterin, an Immune Activation Marker, Independently Predicts Disease Progression in Advanced HIV-1 Infection

Description of an efficacious behavioral peer-driven intervention to reduce racial/ethnic disparities in AIDS clinical trials

Changes in Weight and Lean Body Mass during Highly Active Antiretroviral Therapy

An Approach to the Validation of Markers for Use in AIDS Clinical Trials

Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

Gender differences in attitudes toward AIDS clinical trials among urban HIV-infected individuals from racial and ethnic minority backgrounds

Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study

Safety and Immunogenicity of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B gag/pol/nef Vaccine in Healthy Adults

Intranasal Transmission of Hepatitis C Virus: Virological and Clinical Evidence

Predictors and Outcome of Multidrug-Resistant Tuberculosis

Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points : A meta-analysis

HIV Incidence Among Injection Drug Users in New York City, 1990 to 2002: Use of Serologic Test Algorithm to Assess Expansion of HIV Prevention Services

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001

Implications of Anemia in Human Immunodeficiency Virus, Cancer, and Hepatitis C Virus

Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients

Comparative in-vitro activities of RP59500 (quinupristin/dalfopristin), CL 329,998, CL 331,002, trovafloxacin, clinafloxacin, teicoplanin and vancomycin against Gram-positive bacteria

Comparison of Once-Daily versus Twice-Daily Combination Antiretroviral Therapy in Treatment-Naive Patients: Results of AIDS Clinical Trials Group (ACTG) A5073, a 48-Week Randomized Controlled Trial

AIDS 1998. Clinical treatment: overview

Prevalence of human herpesvirus 8 DNA sequences in several patient populations

A Randomized, Partially Blinded Phase 2 Trial of Antiretroviral Therapy, HIV‐Specific Immunizations, and Interleukin‐2 Cycles to Promote Efficient Control of Viral Replication (ACTG A5024)

Outcomes by Sex Following Treatment Initiation With Atazanavir Plus Ritonavir or Efavirenz With Abacavir/Lamivudine or Tenofovir/Emtricitabine

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials

Once-Daily versus Twice-Daily Lopinavir/Ritonavir in Antiretroviral-Naive HIV-Positive Patients: A 48-Week Randomized Clinical Trial

Suchergebnisse filtern